Advertisement
Screener

PFIZER INC (PFE) Repayments of Short-term Debt

PFIZER INC Repayments of Short-term Debt

PFIZER INC (PFE) reported Repayments of Short-term Debt of $0 for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Financing Activities

us-gaap:RepaymentsOfShortTermDebt · last filed 2026-08-04

  • PFIZER INC repayments of short-term debt for the quarter ending 2026-06-28 was $0.00, a 100.00% decline year-over-year.
  • PFIZER INC repayments of short-term debt for the quarter ending 2026-03-29 was $0.00, a 100.00% decline year-over-year.
  • PFIZER INC repayments of short-term debt for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • PFIZER INC repayments of short-term debt for the quarter ending 2025-09-28 was $0.00, a 100.00% decline year-over-year.
  • PFIZER INC repayments of short-term debt for fiscal 2025 was $2.20B, a 80.41% decline from fiscal 2024.
  • PFIZER INC repayments of short-term debt for fiscal 2024 was $11.23B, a 374100.00% increase from fiscal 2023.
  • PFIZER INC repayments of short-term debt for fiscal 2023 was $3.00M, a 99.92% decline from fiscal 2022.
  • PFIZER INC repayments of short-term debt for fiscal 2022 was $3.89B.
Period endRepayments of Short-term Debt 3 monthRepayments of Short-term Debt 3 month as first filedRepayments of Short-term Debt 6 monthRepayments of Short-term Debt 6 month as first filedRepayments of Short-term Debt 9 monthRepayments of Short-term Debt 9 month as first filedRepayments of Short-term Debt 12 monthRepayments of Short-term Debt 12 month as first filed
2026-06-28$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$0.00
10-Q · filed 2026-08-04
$0.00
derived: sum of 3 quarters · filed 2026-08-04
$0.00
derived: sum of 4 quarters · filed 2026-08-04
2026-03-29$0.00
10-Q · filed 2026-05-05
$0.00
derived: sum of 2 quarters · filed 2026-05-05
$0.00
derived: sum of 3 quarters · filed 2026-05-05
$151.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$151.00M
derived: sum of 3 quarters · filed 2026-08-04
$2.20B
10-K · filed 2026-02-26
2025-09-28$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$151.00M
derived: sum of 2 quarters · filed 2026-08-04
$2.20B
10-Q · filed 2025-11-04
$5.65B
derived: sum of 4 quarters · filed 2026-08-04
2025-06-29$151.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$2.20B
10-Q · filed 2026-08-04
$5.65B
derived: sum of 3 quarters · filed 2026-08-04
$8.57B
derived: sum of 4 quarters · filed 2026-08-04
2025-03-30$2.05B
10-Q · filed 2026-05-05
$5.50B
derived: sum of 2 quarters · filed 2026-05-05
$8.42B
derived: sum of 3 quarters · filed 2026-05-05
$12.95B
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$3.45B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$6.37B
derived: sum of 2 quarters · filed 2026-02-26
$10.90B
derived: sum of 3 quarters · filed 2026-02-26
$11.23B
10-K · filed 2026-02-26
2024-09-29$2.92B
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$7.45B
derived: sum of 2 quarters · filed 2025-11-04
$7.77B
10-Q · filed 2025-11-04
$7.78B
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$4.52B
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$4.85B
10-Q · filed 2025-08-05
$4.86B
derived: sum of 3 quarters · filed 2026-02-26
$4.86B
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$328.00M
10-Q · filed 2025-05-05
$331.00M
derived: sum of 2 quarters · filed 2026-02-26
$331.00M
derived: sum of 3 quarters · filed 2026-02-26
$331.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$3.00M
derived: sum of 2 quarters · filed 2026-02-26
$3.00M
derived: sum of 3 quarters · filed 2026-02-26
$3.00M
10-K · filed 2026-02-26
2023-10-01$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04
$0.00
derived: sum of 2 quarters · filed 2024-11-04
$0.00
10-Q · filed 2024-11-04
$0.00
derived: sum of 4 quarters · filed 2025-02-27
2023-07-02$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05
$0.00
10-Q · filed 2024-08-05
$0.00
derived: sum of 3 quarters · filed 2025-02-27
2023-04-02$0.00
10-Q · filed 2024-05-08
$0.00
derived: sum of 2 quarters · filed 2025-02-27
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$3.89B
10-K · filed 2025-02-27
2022-10-02$3.89B
10-Q · filed 2023-11-08
2021-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$0.00
derived: sum of 2 quarters · filed 2024-02-22
$0.00
derived: sum of 3 quarters · filed 2024-02-22
$0.00
10-K · filed 2024-02-22
2021-10-03$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$1.00M
derived: sum of 2 quarters · filed 2022-11-09
$1.00M
10-Q · filed 2022-11-09
$4.75B
derived: sum of 4 quarters · filed 2023-02-23
2021-07-04$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$0.00
10-Q · filed 2021-08-12
$4.75B
derived: sum of 3 quarters · filed 2023-02-23
$9.03B
derived: sum of 4 quarters · filed 2023-02-23
2021-04-04$0.00
10-Q · filed 2021-05-13
$4.75B
derived: sum of 2 quarters · filed 2023-02-23
$9.03B
derived: sum of 3 quarters · filed 2023-02-23
$14.65B
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$4.75B
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$9.03B
derived: sum of 2 quarters · filed 2023-02-23
$14.65B
derived: sum of 3 quarters · filed 2023-02-23
$22.20B
10-K · filed 2023-02-23
2020-09-27$4.28B
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$9.90B
derived: sum of 2 quarters · filed 2021-11-12
$17.45B
10-Q · filed 2021-11-12
$21.74B
derived: sum of 4 quarters · filed 2022-02-24
2020-06-28$5.62B
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$13.17B
10-Q · filed 2021-08-12
$17.46B
derived: sum of 3 quarters · filed 2022-02-24
$19.17B
derived: sum of 4 quarters · filed 2022-02-24
2020-03-29$7.55B
10-Q · filed 2021-05-13
$11.84B
derived: sum of 2 quarters · filed 2022-02-24
$13.55B
derived: sum of 3 quarters · filed 2022-02-24
$14.16B
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$4.29B
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$6.00B
derived: sum of 2 quarters · filed 2022-02-24
$6.61B
derived: sum of 3 quarters · filed 2022-02-24
$8.38B
10-K · filed 2022-02-24
2019-09-29$1.71B
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$2.32B
derived: sum of 2 quarters · filed 2020-11-05
$4.09B
10-Q · filed 2020-11-05
$4.29B
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$609.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$2.38B
10-Q · filed 2020-08-06
$2.57B
derived: sum of 3 quarters · filed 2021-02-25
$3.89B
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$1.77B
10-Q · filed 2020-05-07
$1.96B
derived: sum of 2 quarters · filed 2021-02-25
$3.28B
derived: sum of 3 quarters · filed 2021-02-25
$3.71B
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$198.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$1.52B
derived: sum of 2 quarters · filed 2021-02-25
$1.94B
derived: sum of 3 quarters · filed 2021-02-25
$4.44B
10-K · filed 2021-02-25
2018-09-30$1.32B
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$1.75B
derived: sum of 2 quarters · filed 2019-11-07
$4.24B
10-Q · filed 2019-11-07
$6.53B
derived: sum of 4 quarters · filed 2020-02-27
2018-07-01$428.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$2.92B
10-Q · filed 2019-08-08
$5.21B
derived: sum of 3 quarters · filed 2020-02-27
$7.78B
derived: sum of 4 quarters · filed 2020-02-27
2018-04-01$2.49B
10-Q · filed 2019-05-09
$4.78B
derived: sum of 2 quarters · filed 2020-02-27
$7.35B
derived: sum of 3 quarters · filed 2020-02-27
$9.92B
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$2.29B
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$4.86B
derived: sum of 2 quarters · filed 2020-02-27
$7.43B
derived: sum of 3 quarters · filed 2020-02-27
$9.95B
10-K · filed 2020-02-27
$9.99B
10-K · filed 2018-02-22
2017-10-01$2.57B
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$5.14B
derived: sum of 2 quarters · filed 2018-11-08
$7.66B
10-Q · filed 2018-11-08
$7.69B
10-Q · filed 2017-11-09
$9.43B
derived: sum of 4 quarters · filed 2019-02-28
2017-07-02$2.57B
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$5.09B
10-Q · filed 2018-08-09
$5.11B
10-Q · filed 2017-08-10
$6.86B
derived: sum of 3 quarters · filed 2019-02-28
$7.89B
derived: sum of 4 quarters · filed 2019-02-28
2017-04-02$2.52B
10-Q · filed 2018-05-10
$2.53B
10-Q · filed 2017-05-11
$4.29B
derived: sum of 2 quarters · filed 2019-02-28
$5.32B
derived: sum of 3 quarters · filed 2019-02-28
$6.26B
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$1.77B
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$2.80B
derived: sum of 2 quarters · filed 2019-02-28
$3.74B
derived: sum of 3 quarters · filed 2019-02-28
$5.09B
10-K · filed 2019-02-28
$5.10B
10-K · filed 2017-02-23
2016-10-02$1.03B
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$1.97B
derived: sum of 2 quarters · filed 2017-11-09
$3.32B
10-Q · filed 2017-11-09
$7.27B
derived: sum of 4 quarters · filed 2018-02-22
2016-07-03$941.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
$2.29B
10-Q · filed 2017-08-10
$6.24B
derived: sum of 3 quarters · filed 2018-02-22
$6.25B
derived: sum of 4 quarters · filed 2018-02-22
2016-04-03$1.35B
10-Q · filed 2017-05-11
$5.30B
derived: sum of 2 quarters · filed 2018-02-22
$5.30B
derived: sum of 3 quarters · filed 2018-02-22
$5.32B
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$3.95B
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$3.95B
derived: sum of 2 quarters · filed 2018-02-22
$3.96B
derived: sum of 3 quarters · filed 2018-02-22
$3.96B
10-K · filed 2018-02-22
2015-09-27$5.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$16.00M
derived: sum of 2 quarters · filed 2016-11-10
$16.00M
10-Q · filed 2016-11-10
$15.00M
10-Q · filed 2015-11-05
$23.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-28$11.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
$11.00M
10-Q · filed 2016-08-11
$10.00M
10-Q · filed 2015-08-06
$18.00M
derived: sum of 3 quarters · filed 2017-02-23
$14.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-29$0.00
10-Q · filed 2016-05-12
$7.00M
derived: sum of 2 quarters · filed 2017-02-23
$3.00M
derived: sum of 3 quarters · filed 2017-02-23
$7.00M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$3.00M
derived: sum of 2 quarters · filed 2017-02-23
$7.00M
derived: sum of 3 quarters · filed 2017-02-23
$10.00M
10-K · filed 2017-02-23
2014-09-28-$4.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$0.00
derived: sum of 2 quarters · filed 2015-11-05
$3.00M
10-Q · filed 2015-11-05
$461.00M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-29$4.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$7.00M
10-Q · filed 2015-08-06
$465.00M
derived: sum of 3 quarters · filed 2016-02-29
$1.91B
derived: sum of 4 quarters · filed 2016-02-29
2014-03-30$3.00M
10-Q · filed 2015-05-07
$461.00M
derived: sum of 2 quarters · filed 2016-02-29
$1.90B
derived: sum of 3 quarters · filed 2016-02-29
$3.21B
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$458.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$1.90B
derived: sum of 2 quarters · filed 2016-02-29
$3.20B
derived: sum of 3 quarters · filed 2016-02-29
$4.23B
10-K · filed 2016-02-29
2013-09-29$1.44B
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$2.75B
derived: sum of 2 quarters · filed 2014-11-06
$3.78B
10-Q · filed 2014-11-06
2013-06-30$1.30B
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$2.33B
10-Q · filed 2014-08-07
2013-03-31$1.03B
10-Q · filed 2014-05-08
2012-12-31$8.18B
10-K · filed 2015-02-27
2011-12-31$13.28B
10-K · filed 2014-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64